Xgenera
PrivateLast Round
Seed
Dec 3, 2024
Total Funding Raised
$7.75M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Xgenera operates in AI, Data & Cloud Infrastructure and is based in Southampton. Its latest recorded funding round was a Seed round in December 2024.
Xgenera is a biotechnology company that develops multi-cancer early detection (MCED) diagnostic tests using microRNA biomarkers and machine learning.
Sector
AI, Data & Cloud Infrastructure
Verticals
Cloud Infrastructure, Workflow Automation, DevOps & Containers
Business Model
B2G
Customer Profile
Government Contracts, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Xgenera Comparables
Compare Xgenera with similar companies based on industry and business-model similarity.
No comparables are published for Xgenera. Book a demo to ask about coverage.
Book a demoFor institutional investors. Book with your work email.
Xgenera Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Dec 3, 2024 | ||||
| Grant | Sep 1, 2024 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Xgenera Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Ascension Ventures | Seed |
| QantX | Seed |
| Empirical Ventures | Seed |
| National Institute for Health and Care Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 13, 2026
Monthly visitors grew 44% MoM.
- Aug 21, 2026
Monthly visitors grew 3162% MoM, from 42 to 1.4K.
For institutional investors. Book with your work email.
Xgenera Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Xgenera's valuation, stock price, and market status.
Is Xgenera a public or private company?
Xgenera is a private company.
What is the current stock price of Xgenera?
Xgenera is a private company, so its shares have no public market price. Caplight tracks Xgenera's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Xgenera worth (valuation)?
Valuation information for Xgenera is not publicly available.
Can I buy Xgenera stock?
Xgenera shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Xgenera's last funding round?
Xgenera's most recent funding round was Seed on December 3, 2024.
Who are the main investors in Xgenera?
Key investors in Xgenera include QantX.
Will Xgenera IPO soon?
No public IPO plans have been announced for Xgenera.
How can I track Xgenera secondary market activity?
Caplight tracks bids, offers, and trades in Xgenera's shares on secondary markets.